'340b drug pricing program' presentation slideshows

The 3 Ps of the 340B Drug Pricing Program: Participation, Pricing and Program Integrity

The 3 Ps of the 340B Drug Pricing Program: Participation, Pricing and Program Integrity. CDR Krista M. Pedley, PharmD, MS Director U.S. Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau Office of Pharmacy Affairs. August 14, 2012.

540 views • 35 slides

Pharmacy Access: The 340B Program June 24, 2008

Health Resources and Services Administration 2008 Primary Health Care All-Grantee Meeting. Pharmacy Access: The 340B Program June 24, 2008. Ann Ferrero & Bhavani Pattabiraman Public Health Analysts U.S. Department of Health and Human Services Health Resources and Services Administration

473 views • 32 slides

465 views • 27 slides

485 views • 27 slides

Gilead Sciences, Inc.

Gilead Sciences, Inc. NASDAQ: GILD. Vivek Vinayak Patrick Leake. Company Background. Research-based pharmaceutical company Primary focus in HIV/AIDS, liver diseases, respiratory and cardiovascular, and cancer 16 products (6 HIV, 2 Liver, 3 Cardiovascular, 2 Respiratory, 3 Other).

745 views • 12 slides

Optimizing The 340B Program

Optimizing The 340B Program. Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services. This educational product created by: Health Resources and Services Administration | Office of Pharmacy Affairs 340B Peer-to-Peer Program.

196 views • 10 slides